Hypervision Surgical, a medical technology startup developing AI-powered next-generation intelligent surgical imaging systems, raised £17 million in a Series A funding round.
Heal Capital led the investment round with participation from Angelini Ventures, IP Group, Daycrest, HERAN Partners, Redalpine, LifeX Ventures, ZEISS Ventures, and SINC Fund – managed by SAGES Ingenuity, the subsidiary of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES).
The Series A financing will accelerate commercial adoption of Hypervision’s Hyperspectral Intelligence platform, expand clinical adoption, and advance development of the company’s next-generation hyperspectral sensing technology – co-developed with imec, an independent nanoelectronics R&D hub.
Michael Ebner, CEO and co-founder of Hypervision Surgical, said: “This Series A marks a major milestone in our mission to power surgical intelligence through hyperspectral vision.”
“By combining advanced spectral sensing with cloud-enabled AI analytics, we are building a new intelligence layer in surgery – giving surgeons real-time insights into tissue that were previously impossible to access,” added Michael Ebner.
Looking ahead, the company aims to integrate Hyperspectral Intelligence across laparoscopic, robotic, microscopic, and endoscopic surgical platforms – enabling data-rich surgical vision across hundreds of millions of procedures annually.
Hypervision Surgical is a medical technology company and a King’s College London spin-out pioneering hyperspectral imaging for surgery. Its Hyperspectral Intelligence platform integrates proprietary spectral sensing and patented AI analytics to deliver quantitative tissue insights beyond human vision, powering the next generation of intelligent surgical imaging systems.
Digital health companies, including medical imaging startups, have secured more than $180 billion in funding to date, according to our recent Funding Database. More recently, SquareMind, a France-based robotics startup developing AI-powered dermatology solutions to make high-quality skin exams more efficient and accessible, raised $18 million in a pre-Series A funding round.
In another deal, lmanac Health, a provider of an AI-powered point-of-care evidence-based clinical decision support platform for healthcare providers, raised $10 million in Seed funding.